A few important points:
1. Antidepressants can truly change people's lives. Not everyone's, and they're not the only treatment that works. Somehow this reporter tends to consistently overlook the clear evidence of benefit (I think this recent meta-analysis was posted on hn: https://www.ncbi.nlm.nih.gov/pubmed/29477251)
2. Withdrawal symptoms are common if antidepressants are stopped abruptly - some of the folks who reported these symptoms originally have been favorite targets of Benedict Carey, ironically (https://www.ncbi.nlm.nih.gov/pubmed/9396960). That's why docs encourage tapering antidepressants.
3. The article doesn't distinguish between this sort of short-term withdrawal (common), and longer-term problems with discontinuation (likely quite rare) - they're very very different phenomena.
4. In some cases, difficulty with discontinuing longer-term is a result of persistent depression and anxiety (or returning depression and anxiety). It's not polite to point this out.
5. It's hard to imagine the Times writing an article about the problem with statins being that, once you stop them, cholesterol increases again.
6. If there were substantial long-term risks associated with antidepressants, we would have seen them - and believe me, people have looked and are looking.
7. BUT - we /do/ need more research to understand long-term effects of antidepressant treatment; this absence of systematic long-term study is true for most meds, frankly, but that's no excuse. My question would be: Who pays for it? There's no shortage of investigators who would be delighted to study it. But try getting a foundation, or NIH, to support such a study.
/rant